Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; SPY004; SPY130, a combination of anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination of anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.

Spyre Therapeutics Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB), Spyre Therapeutics (SYRE) and N...

Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Spyre Therapeutics (SYRE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and Revolution Medicines (...

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE) and Revolution Medicines (RVMD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Spyre Therapeutic...

Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Spyre Therapeutics (SYRE)

As the market witnesses a relief rally this April, investors are turning toward stocks with strong momentum and analyst backing. For those looking ...

3 Best Trending Stocks, According to Analysts – 4/16/2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Delcath Systems (DCTH), HeartFlow, Inc. (HTFL) and S...

Analysts Are Bullish on Top Healthcare Stocks: Delcath Systems (DCTH), HeartFlow, Inc. (HTFL)

Spyre Therapeutics ( ($SYRE) ) has shared an update. On April 13, 2026, Spyre Therapeutics suspended and terminated its at-the-market prospectus fo...

Spyre Therapeutics Pauses At-The-Market Equity Offering Program

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oruka Therapeutics (ORKA) and Spyre Therapeutics (SY...

Analysts’ Top Healthcare Picks: Oruka Therapeutics (ORKA), Spyre Therapeutics (SYRE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and Ocular Therapeutix (OC...

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE) and Ocular Therapeutix (OCUL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and Regeneron (REGN) with ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Spyre Therapeutics ( ($SYRE) ) has shared an update. On April 13, 2026, Spyre Therapeutics reported positive 12-week induction topline results from...

Spyre Therapeutics Reports Positive Phase 2 SKYLINE Results

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), ProQR (PRQR) and Spyre Therapeutics ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SYRE	$69.67	+0.62%	601.09K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SYRE	$69.67	+0.6%	601.09K
3
4
5
6

SYRE

SYRE

Get Spyre Therapeutics Inc. Data in Excel

Get Spyre Therapeutics Inc. Data in Excel